imilars and follow-on biologics seize market share - our new report explains how. Many biologic patents will expire during our forecast period. There is mounting pressure from governments, insurers an...
discussing data, opportunities and prospects. This study investigates biosimilars (follow-on biologics). It lets you assess forecasted sales at world market, therapeutic submarket and nationa...